Literature DB >> 6165288

Tolerability of pure fibroblast interferon in man.

A Billiau, J W Heine, J Van Damme, H Heremans, P De Somer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6165288     DOI： 10.1111/j.1749-6632.1980.tb20637.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  5 in total

Review 1.  Interferon therapy: pharmacokinetic and pharmacological aspects.

Authors:  A Billiau
Journal:  Arch Virol       Date:  1981       Impact factor: 2.574

Review 2.  Interferons and interferon inducers: development of clinical usefulness and therapeutic promise.

Authors:  R B Pollard
Journal:  Drugs       Date:  1982 Jan-Feb       Impact factor: 9.546

3.  Mechanisms of fever induced by recombinant human interferon.

Authors:  C A Dinarello; H A Bernheim; G W Duff; H V Le; T L Nagabhushan; N C Hamilton; F Coceani
Journal:  J Clin Invest       Date:  1984-09       Impact factor: 14.808

Review 4.  The clinical application of fibroblast interferon--an overview.

Authors:  A Billiau
Journal:  Med Oncol Tumor Pharmacother       Date:  1984

5.  Interdependent and independent roles of type I interferons and IL-6 in innate immune, neuroinflammatory and sickness behaviour responses to systemic poly I:C.

Authors:  Carol Murray; Éadaoin W Griffin; Elaine O'Loughlin; Aoife Lyons; Eoin Sherwin; Suaad Ahmed; Nigel J Stevenson; Andrew Harkin; Colm Cunningham
Journal:  Brain Behav Immun       Date:  2015-04-18       Impact factor: 7.217
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.